<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>4482</billNumber>
    <committeeReports />
    <cboCostEstimates />
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2019-04-04T19:51:55Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</b></p> <p>This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II or III unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.</p> <p>Certain opioid prescriptions are not subject to the limit (e.g., an opioid that is approved and prescribed for the treatment of an opioid use disorder).</p> <p>The Food and Drug Administration (FDA) must continue to work with stakeholders to promote the development of abuse-deterrent opioid formulations.</p> <p>The bill requires: (1) the Government Accountability Office to study and report on health care policy changes that may have contributed to the increase in opioid overdoses and deaths, and (2) the FDA to study the feasibility of replacing opioid prescribing limits established by this bill with evidence-based clinical guidelines for opioid prescribing. <br> </p>]]></text>
          <versionCode>00</versionCode>
          <actionDate>2017-11-29</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2017-11-29T05:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <notes />
    <createDate>2017-11-30T03:11:17Z</createDate>
    <cosponsors>
      <item>
        <bioguideId>R000586</bioguideId>
        <party>R</party>
        <sponsorshipDate>2017-11-29</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName>B.</middleName>
        <district>16</district>
        <state>OH</state>
        <fullName>Rep. Renacci, James B. [R-OH-16]</fullName>
        <lastName>Renacci</lastName>
        <firstName>James</firstName>
        <identifiers>
          <bioguideId>R000586</bioguideId>
          <gpoId>8106</gpoId>
          <lisID>2048</lisID>
        </identifiers>
      </item>
      <item>
        <bioguideId>B001305</bioguideId>
        <party>R</party>
        <sponsorshipDate>2018-01-11</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <middleName />
        <district>13</district>
        <state>NC</state>
        <fullName>Rep. Budd, Ted [R-NC-13]</fullName>
        <lastName>Budd</lastName>
        <firstName>Ted</firstName>
        <identifiers>
          <lisID>2336</lisID>
          <gpoId />
          <bioguideId>B001305</bioguideId>
        </identifiers>
      </item>
    </cosponsors>
    <originChamber>House</originChamber>
    <amendments />
    <updateDate>2019-11-15T21:33:55Z</updateDate>
    <relatedBills>
      <item>
        <congress>115</congress>
        <latestAction>
          <actionDate>2017-12-13</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <number>4408</number>
        <type>HR</type>
        <latestTitle>Opioid Addiction Prevention Act of 2017</latestTitle>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <congress>115</congress>
        <latestAction>
          <actionDate>2017-04-07</actionDate>
          <text>Read twice and referred to the Committee on the Judiciary.</text>
        </latestAction>
        <number>892</number>
        <type>S</type>
        <latestTitle>Opioid Addiction Prevention Act of 2017</latestTitle>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <congress>115</congress>
        <latestAction>
          <actionDate>2018-05-22</actionDate>
          <text>Referred to the House Committee on Energy and Commerce.</text>
        </latestAction>
        <number>5914</number>
        <type>HR</type>
        <latestTitle>To require a study and report on policy and regulatory changes that may have contributed to the opioid epidemic.</latestTitle>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <latestAction>
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
      <actionDate>2018-01-09</actionDate>
      <links />
    </latestAction>
    <introducedDate>2017-11-29</introducedDate>
    <laws />
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care coverage and access</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>State and local government operations</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <calendarNumbers />
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2017-11-29T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr4482ih/xml/BILLS-115hr4482ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <version>1.0.0</version>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <recordedVotes />
    <sponsors>
      <item>
        <bioguideId>M001187</bioguideId>
        <state>NC</state>
        <party>R</party>
        <fullName>Rep. Meadows, Mark [R-NC-11]</fullName>
        <firstName>Mark</firstName>
        <lastName>Meadows</lastName>
        <identifiers>
          <bioguideId>M001187</bioguideId>
          <lisID>2142</lisID>
          <gpoId />
        </identifiers>
        <byRequestType />
        <middleName />
        <district>11</district>
      </item>
    </sponsors>
    <billType>HR</billType>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 194 (Wednesday, November 29, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. MEADOWS:H.R. 4482.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause I states ``The Congress shallhave Power To . . . provide for the . . . general Welfare ofthe United States . . .'' And, Article I, Section 8, Clause 3states ``The Congress shall have Power To . . . regulateCommerce . . . among the several States . . . ''[Page H9516]</pre>]]></constitutionalAuthorityStatementText>
    <title>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</title>
    <congress>115</congress>
    <committees>
      <billCommittees>
        <item>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <date>2018-01-09T17:00:37Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Crime, Terrorism, and Homeland Security Subcommittee</name>
              <systemCode>hsju08</systemCode>
            </item>
          </subcommittees>
          <type>Standing</type>
          <systemCode>hsju00</systemCode>
          <chamber>House</chamber>
          <name>Judiciary Committee</name>
          <activities>
            <item>
              <date>2017-11-29T15:00:16Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <date>2017-12-01T16:50:54Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <date>2017-11-29T15:00:11Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>6</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2018-01-09</actionDate>
        <committee>
          <name>Crime, Terrorism, and Homeland Security Subcommittee</name>
          <systemCode>hsju08</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-12-01</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-11-29</actionDate>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      </item>
      <item>
        <actionDate>2017-11-29</actionDate>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      </item>
      <item>
        <actionDate>2017-11-29</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <item>
        <actionDate>2017-11-29</actionDate>
        <committee />
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
      </item>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>2</placeholderTextForH>
        <billReferrals>2</billReferrals>
      </actionTypeCounts>
    </actions>
    <titles>
      <item>
        <title>To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.</title>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <title>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</title>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <title>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</title>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <title>Opioid Abuse Deterrence, Research, and Recovery Act of 2017</title>
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
        <chamberCode />
      </item>
    </titles>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

